Board of Governors

CancerLinQ is governed by a volunteer Board of Governors elected by its sole member, the American Society of Clinical Oncology. The CancerLinQ Chief Executive Officer serves on the Board as well. Board members are not paid for their service, although they receive reimbursement for direct expenses related to the conduct of their Board duties.

View the Disclosures for the Board of Governors below each individual’s name. Please direct any questions related to Board members' disclosures to COI@asco.org.
 

• Carmen Jackson, PMP
  Interim CEO, CancerLinQ
   

• Clifford A. Hudis, MD, FACP, FASCO, CEO, Chair 
  ASCO
  View Disclosure
   

• Ronald Andrews
  OncoCyte
  View Disclosure
  
  
  
   

• Howard Burris III, MD, FACP, FASCO
  Sarah Cannon
  View Disclosure
   

• Eric P. Winer, MD, FASCO
  Yale Cancer Center
  View Disclosure
   

• Aaron Sasson
  Lanetix
   

• Robin Zon, MD, FACP, FASCO
  Michiana Hematology Oncology
  View Disclosure